Introduction
In response to growing concerns about declining male sperm function globally, HDX Cell Bank, based in Tokyo, has introduced sperm health testing as part of corporate health check options. This initiative aims to enhance male reproductive awareness and facilitate better planning for conception.
The Context
Recently, a noticeable decline in male sperm functionality has been observed worldwide. In Japan, however, opportunities for men to assess their reproductive health are limited. Often, challenges related to pregnancy and childbirth only become evident once couples enter infertility treatments. While advancements in femtech and egg freezing options have significantly empowered women's reproductive health choices, the same cannot be said for men, who still lack accessible ways to understand their reproductive status. This disparity emphasizes the need for a shared foundation for reproductive planning between genders.
Overview of Services
HDX Cell Bank's new tests are available as options within corporate health screenings, offering the following evaluations:
- - WHO Standard Semen Analysis: This test evaluates semen volume, sperm concentration, and motility.
- - Sperm DNA Fragmentation Index (DFI): A precise assessment that measures sperm DNA integrity.
Implementation Method
The testing process utilizes specialized collection and transport equipment to enable home testing, which eliminates the need for clinic visits. Collected samples are securely sent to testing facilities in temperature-controlled containers, making the tests not only more convenient but also less intimidating for participants.
Significance of the Initiative
This initiative is expected to yield several positive outcomes:
- - Promotion of preconception care
- - Support for life design among younger demographics
- - Introduction of new health metrics within corporate environments
- - Increased participation rates due to at-home testing options
- - Reduction of the information gap between men and women regarding reproductive health.
Insights from COO Yumi Yamauchi
Yumi Yamauchi, COO of HDX Cell Bank, comments on the current status of reproductive health awareness.
"The progress in femtech and the adoption of egg freezing have brought significant advancements to women's reproductive health choices. Yet, structural biases still exist, often centering reproductive issues around women alone. It's crucial that preparation for pregnancy and childbirth is a shared responsibility between partners. Currently, opportunities for men to understand their health are scarce, resulting in a lack of necessary information for informed decision-making. Our initiative aims to visualize male reproductive health, allowing for a more equitable and fulfilling approach to life planning."
Future Plans
Looking ahead, HDX Cell Bank plans to enhance its services by integrating testing data visualization, lifestyle habits tracking, and connections to preventive sperm freezing options. These strategies are geared toward building a comprehensive framework for male reproductive health.
Important Notes
The tests, including the WHO standard semen analysis and sperm DNA fragmentation index, are conducted by partnered testing facilities and medical institutions. HDX Cell Bank does not provide medical services, nor is this program designed for diagnosis or treatment purposes; rather, it serves as a tool for individuals to understand their health and plan for the future effectively.
Company Information
HDX Cell Bank, Inc.
Headquarters: 2-28-415 Shimomiya, Shinjuku, Tokyo
MIRAIBANK Center: 3-3-14 Oowada, Niiza, Saitama
Official Website:
MIRAIFAMILY
Founded: July 2015
CEO: Founder Tohru Mukai